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Liver-Derived Fetal Hematopoietic Stem Cells Selectively and Preferentially Home to the Fetal Bone Marrow
By Esmail D. Zanjani, Joao L. Ascensao, and Mehdi Tavassoli
In the course of ontogeny, the homing site for the hematopoietic stem cells (HSC) moves with certain predictability from the yolk sac to the liver/spleen and then to the marrow. The pattern of this migration has thus far been established mostly on a morphologic basis. To delineate further the course of this migration and to gain insight into its possible mechanism, we used in utero transplantation of allogeneic or xenogeneic HSC in preimmune sheep fetuses. Sex chromosome, type of hemoglobin, and species-specific surface markers were used to follow the path of transplanted cells in the fetus. Before the development of the bone marrow, transplanted HSC (liver-or marrow-derived) homed exclusively to the liver/spleen. With the development of marrow, around day 60 of gestation (term, 145 days), homing occurred also in the nascent marrow and by day 80 transplanted cells homed exclusively to the marrow. This suggests that there may be a hierarchy in homing sites, with
HE COURSE OF ONTOGENY is associated with an
T orderly and predictable switch in the sites of hematopoiesis. In mammals the process begins in the yolk sac, migrates to the liver and spleen, and finally lodges in the bone marrow (BM), which remains hematopoietic throughout life.'-3 The major evidence for presence of this migration is derived from morphologic studies in different tissues in the course of fetal development. This evidence was obtained mostly during the first half of this century when morphologic studies were in vogue. See the work by Tavassoli4 for a historical perspective. Thus, this pattern still appears more provisional than solid. Subsequent studies, using progenitor cell assays, suggested that the change in the sites of hematopoiesis is consequent to the migration of hematopoietic stem cells (HSC), via the blood stream, from one tissue to a n~t h e r ,~.~ although generation of stem cells in the new sites of hematopoiesis has also been suggested.'" The origin of all HSC may be in the yolk sac, but as one tissue loses its potential to "home," nurture HSC, and sustain hematopoiesis, these cells move to other tissues that have gained this homing potential. However, it is not known how one tissue loses its support potential for hematopoiesis to another's gain. It is also possible that the HSC may be altered in the course of development, and such putative alterations could facilitate their migration in the fetus. The application of newer techniques to the study of hematopoietic cell kinetics during the course of this migration, and gestation in general, has been limited. Thus, the kinetics of hematopoiesis during fetal development is still not well delineated. Transplantation techniques, cell markers, and newer techniques of cellular and molecular biology have rarely been applied to the study of this area. The advent of techniques for in utero HSC transplantation' and the use of cell markers to follow-up the paths and the distribution of these cells'o~'' have opened a vista for studying the dynamics of HSC migration during fetal development.
In the present work, we have used in utero transplantation techniques in preimmune sheep to explore this question. We transplanted liver-and marrow-derived HSC into fetuses of various gestational ages. We now report that early in the those of the marrow having higher affinity than those of liver/spleen. Interestingly, despite a change in homing that was followed by the expansion of the marrow compartment of HSC (ie, HSC proliferation), these cells did not participate actively in blood cell formation during most of the prenatal period. Liver remained the major hematopoietic organ throughout the gestation. It was only during the perinatal period that this organ assumed the function of hematopoiesis from the liver. This lack of expression of HSC in fetal marrow can possibly be attributable to the immaturity of marrow stroma required for differentiation and maturation of progenitors and the orderly egress of mature cells into the blood stream. The availability of this model allows us to begin studies in the molecular mechanism of stem cell homing in vivo during ontogeny. course of development of BM (between 60 and 80 days in sheep), both liver-and marrow-derived HSC home preferentially to the marrow and appear to proliferate, but do not appear to differentiate and mature. Hence, they may not contribute to circulating blood cell formation during most of the prenatal period. These findings may possibly suggest a hierarchy of hematopoietic sites with regard to the engraftment potential of HSC. Our results also suggest the duality of homing and proliferation of HSC on the one hand and their differentiation on the other. Thus, while HSC can pool in the fetal marrow, fetal liver still cames the burden of hematopoiesis until near the end of gestation. For xenograft studies, human fetal liver was obtained from the products of therapeutic abortion (12 to 14 weeks) as a source of donor HSC. Informed consent was obtained from the mother according to the protocols approved by the Institutional Review Board. After informed consent, BM was also aspirated from adult human volunteers. Human cell suspensions were prepared as described and transplanted into 50-day-old sheep fetuses. BM and blood samples were obtained from the recipients at intervals before and after birth and studied for the expression of surface antigens CD45 and CD14 using combined monoclonal antibodies (MoAbs) (Leucogate; Becton Dickinson, Mountain View, CA) to these human surface antigens. Flow cytometric methods have been described previously in detail.i0." A microbubble technique was used for in utero transplantation, a technique that has also been previously described in Donor cell infusions were achieved by accessing the fetus as follows: After a 48-hour fast, the maternal ewes were sedated with intramuscular ketamine (10 mg/kg) and received 0.5% to 1.0% halothane-oxygen mixture by inhalation via an endotracheal tube. The external jugular vein was cannulated with a 16-gauge angiocath for administration of intravenous (IV) fluids and antibiotics (penicillin, 2 million U/ kanamycin, 400 mg). The uterus was exposed by a lower midline incision. The fetal abdomen was exposed through a small hysterotomy. Donor cells were then injected intraperitoneally. Uterine and maternal body walls were closed as Monitoring of the engraftment. Fetuses were killed at intervals after donor cell infusion, and liver, spleen, BM, and blood were obtained to study transplantation markers (Hb type and karyotyping of progenitor cell colonies). Because the hematopoietic phase of liver and spleen is temporally superimposed in the fetus, the two tissues were combined in these studies. All surviving recipients were examined for evidence of donor cell engraftment at birth and at intervals thereafter. Peripheral blood cells and aliquots of liver/spleen or BM cells were analyzed for the presence of donor karyotype after PHA stimulation. Liver/spleen or BM cells (2 to 4 X IOs cells/mL) were also cultured in 0.9% methylcellulose in the presence of FSS (30%), IMDM, erythropoietin ( I U/mL), and a preparation of sheep/human PHA-LCM (PHA-stimulated leukocyte conditioned medium; 5% vol/ vol), and incubated at 37"C, 5% COz in humidified air. Cultures were processed for karyotyping of erythroid (BFU-E), myeloid (CFU-GM),
MATERIALS AND METHODS

Experimental
Donor cells and transplantation procedure.
and multipotent (CFU-mix) hematopoietic progenitors at day 9 (sheep) or 19 (human) of ~u l t u r e .~"~
RESULTS
Tissue distribution of donor cells. Four groups of type B
fetuses (60 days old) were established. The fetuses in groups 1 and 2 were transplanted with different preparations of cells from livers of preimmune type A fetal sheep, whereas the animals in groups 3 and 4 were given BM cells from type A adult sheep. Liver/spleen and BM were obtained from four recipients in each group on days 70 and 80 of gestation (ie, I O or 20 days posttransplant) and analyzed for presence of donor cells. Table 1 shows the relative distribution of donor cells in the liver and BM of the recipient fetuses. Irrespective of the source of donor HSC (fetal liver or adult marrow), homing occurred primarily and preferentially in the marrow. The frequency of donor cells in the marrow appeared to increase with time, as the development of marrow proceeded (compare 70 and 80 days of gestation). However, further data points are needed to reach a firm conclusion on this point. Nonetheless, this tendency suggested that marrow homing sites may have a higher affinity than those of the liver.
It must be emphasized that Table 1 Although it is possible that the decrease in the relative distribution of donor progenitors in the liver is associated with the increase in the size and cellularity of the liver during the study period (resulting in a dilution effect), it should be noted that a majority (>90%) of hepatocytes were removed from the liver preparations by gravity sedimentation before culture. It is also reasonable to assume that an increase in liver size during the 10-to 20-day posttransplant period would be accompanied by a proportional increase in hematopoietic progenitor compartment so that the relative percent would remain constant, as we show in Table 1 . Figure 1 shows similar relative distribution patterns for liver-derived HSC (from donor fetuses at 50 days of gestation) in the recipient fetuses as a function of gestational age of the host and time after transplantation. Again, this is not the percent of donor cells engrafted as is the case in Figs 2 and 3. Rather, the values in Fig 1 show the relative distribution of donor cells in various host tissues. The overall level of donor cell engraftment was estimated at 11.3% ? 4.5% in these animals. This figure shows that at day 50 of gestation donor cells "homed" exclusively to the liver/spleen. At this stage BM had not yet deve10ped.l~ The skeleton was entirely cartilaginous. Between days 50 and 60, as a result of invasion of cartilage by blood vessels, the process of endochondral osteogenesis set in. This led to the development of some BM space by day 60. Apparently, marrow homing sites became available to the donor cells, which then partially engrafted the marrow. With further development of the BM spaces15 and the expansion of marrow homing sites, an increasingly larger proportion of donor cells seeded the newly developing tissue so that by days 80 to 100 donor cells primarily "homed" to the marrow. Thus, the shifting in the homing sites between liver and BM occurred between 60 and 80 days of gestation. At no time during this period did donor cell progenitors or their hemoglobinized progeny appear in the blood (Fig 1) .
The absence of donor cell expression in the blood, noted in the previous set of experiments, led us to extend these studies into the perinatal period. Figure 2A shows the proportion of donor type Hb made by erythroid progenitors in marrow at intervals after transplantation. It will be noted that while donor erythroid progenitors were consistently present in the marrow, constituting a small but fairly stable proportion of the chimeric tissue, donor mature red blood cells appeared in the blood quite late in the course of gestation. This occurred around the time of birth. Their proportion in both the blood and marrow increased after birth, indicating that their differentiation and expression in the marrow was associated with cell release into the blood. Figure 2B shows similar data obtained by the use of sex chromosomes as the marker. Again, cells and progenitors exhibiting donor karyotype were readily detected in the marrow before birth but not in the blood. However, at birth and thereafter, cells containing the sex chromosome marker of the donor were evident in the blood and their relative proportion appeared to increase slightly with time.
Thus, irrespective of the marker used, the expression of donor cells in the blood appeared late in gestation, near birth.
Studies in xenogrufls.
To enhance the specificity and sensitivity of detection of donor cells, human-ovine xenografts were used. We have previously reported the engraftment and long-term expression of human HSC in preimmune sheep fetuses.lO," We have also shown the specificity of donor cell (100) (120) (Birth) detection in this system using flow cytometry and combined MoAbs to CD45 and CD 14. The specificity is superior to Hb and sex chromosome markers and, thus, represents a significantly more sensitive detection procedure.
In the present study we used human fetal liver (12 to 14 weeks of gestation) as a source of donor HSC. Human cell suspensions were prepared as described' I and transplanted into 50-day-old sheep fetuses. BM and blood samples were obtained from recipients at intervals before and after birth and studied for the expression of surface antigens CD45 and CD 14.
In agreement with data presented in Fig 2, the results shown in Fig 3 indicate that donor human cells were not expressed in blood until birth, although they were present in the chimeric marrow. However, at birth significant numbers of cells expressing human surface CD antigen were detected in the blood of chimeric lambs.
Because fetal Hb consists of two a-and two P-chains, Hb-producing donor and host cells cannot be Hb switching.
readily distinguished when this marker is used. They can be distinguished only when Hb production switches from fetal to adult system, and the donor marker Hb A (a2/32A) can be recognized from the host Hb B (a2/32B).
In the present studies (Fig 4) , we searched for the appearance of the two types of Hb as a function of time after transplantation. Hb B (host type) first appeared by day 100, indicating that fetal to adult Hb switch had occurred during this stage of development. Its proportion gradually increased and stabilized around the time of birth. However, Hb A (donor type) first appeared in the blood at day 140 of gestation, only a few days before birth (gestation period 145 days). These results further indicate that donor cells did not differentiate to enter the blood stream until the perinatal period when BM presumably assumed the function of hematopoiesis.
DISCUSSION
These data substantiate, by the use of in utero transplantation technique and cell marker studies, the migration in the site of hematopoiesis from liver to the BM. Such a migration has been previously described by morphologic studi e~. ' .~
Our data indicate that, in sheep, the preferential homing of transplanted HSC to the marrow occurs between days 60 and 80 of gestation and this is concurrent with the development of BM.I5 Our data further provide the basis for two conceptual frameworks regarding the switch in the sites of hematopoiesis during the course of ontogeny.
Firstly, the preferential and selective homing of HSC, to the marrow, even when they are liver-derived, suggests the possibility that there may exist a hierarchy with regard to the homing sites. In this hierarchy, BM could have the highest affinity for the homing of transplanted HSC. When appro- planted in each sheep fetus. Fetuses were killed periodically and blood and marrow cells were examined by flow cytometric analysis, as described previously," for expression of CD45/CD14 surface antigens. While a small fraction of marrow cells consistently exhibited these antigens, their expression in blood began only at birth and thereafter. This confirms that these cells do not contribute to blood cell formation until marrow has assumed the hematopoietic function from the liver during the perinatal period.
use only.
For priate marrow sites are not available, cells can still home to the liver/spleen; but once the marrow spaces have developed, its homing potential supersedes that of other hematopoietic tissues. This is, despite the liver/spleen remaining, the major hematopoietic tissue until birth. It is possible that a similar traffic of endogenous HSC exists, via the blood stream, in the direction of the newly developed marrow; their presence in the blood stream has been reported during this period.'~~ Hence, transplanted HSC would be in competition for engraftment with endogenous HSC. This may explain our present observation that only a fraction of grafted cells in the marrow display donor cell marker. This fraction can possibly be increased by increasing the dose of the graft or, better still, by repetitive grafting during this period.' ' Confirmation of this "hierarchy" hypothesis may require ablation of one tissue and observation on the subsequent grafting patterns. Further understanding of the molecular basis of engraftment and the differences that they may display in the two tissues (liver and marrow) could also help in verifying or dispelling this hypothesis. A similar hierarchy of affinity can possibly explain the migration of HSC from the yolk sac to the liver/spleen.
An alternative interpretation to the presence of a hierarchy of homing site affinity is that all homing sites in the liver/ spleen may be occupied by endogenous HSC and migrating HSC can only home to the developing marrow. However, this alternative was ruled out in the present studies by the observation that before the development of marrow, nearly all detectable transplanted HSC homed to the liver/spleen. The availability of homing sites in the liver is likely associated with the continued growth of this organ during ontogeny. It is interesting that in adult murine marrow it has been shown that hypertransfusion with HSC still leads to homing of HSC, although the hematopoietic marrow is in a steady state of equilibrium, and requires no new infusion of HSC.16,'7 The nature of HSC homing to the BM has been studied at a molecular and one recognition molecule has been purified.2' Other molecules may also be involved, and, in fact, there are suggestions that a complicated molecular system may be involved in this process?2-26 Whether a similar molecule with a lower affinity exists in the liver/spleen or an entirely different molecular basis exists for homing in these tissues is unclear. Data in the mature murine model suggest the latter possibility,22 but the question deserves to be studied further.
Our results also suggest that while transplanted HSC seed the newly developed marrow, they do not appear to differentiate and mature; therefore, they do not contribute to the formation of circulating blood cells in the fetus. In these studies no detectable progeny of donor cells appeared in the circulating blood until the end of gestation. It is possible that the absence of differentiation products of donor cells in blood was a reflection of our inability to detect the relatively low levels of donor HSC-derived products that became detectable near birth after accumulation in circulation. While this remains a possibility in detecting donor (sheep) Hb, the fact that we were unable to detect human-derived cells with the more sensitive techniques indicate that the marrow may not support hematopoiesis in a significant way during this period.
Despite the absence of donor HSC progeny in the blood, their presence could be detected persistently in the marrow, indicating that engraftment had occurred. This suggests the duality of the homing and differentiation phenomena. From the very initial stage of marrow development to the birth, when marrow assumes the function of hematopoiesis, this tissue is capable of engraftment of circulating stem cells, but appears not to support their differentiation and maturation. Therefore, this period in the course of ontogeny is optimal for the study of homing per se, independent of HSC differentiation. That during this phase, HSC differentiation and maturation does not occur may be the result of immaturity of marrow stromal elements required for the support of hematopoiesis. Subsequent maturation of the stromal machinery leads, around birth, to the ability of marrow to support the differentiation and maturation of HSC: Marrow is then initiated to its hematopoietic function, and liver/spleen cease to be hematopoietic. Therefore, this phase may also provide a suitable model for the study of stromal function in supporting HSC differentiation and maturation. If this interpretation is correct (and it needs to be verified by the study of stromal potential in vitro), the nature of stromal immaturity should be further worked out.
Alternatively hematopoiesis during this period could be ineffective; ie, only immature hematopoietic progenitors use only. could survive, thus delaying the onset of donor-derived blood cell production. Our data do not entirely support this hypothesis because committed erythroid progenitors could be detected in BM. Still the data available in the literature clearly show that the egress of red blood cells from BM occurs because of lack of fibronectin receptors in red blood cells.23 Similarly, it is possible that release of cells from the BM in this model was impaired because of a defect in the maturation of BM. Encouraging the marrow to support the differentiation and egress of mature cells of donor origin into circulation (or other tissue sites) early in gestation may have a significant impact on the efficacy of in utero stem cell transplant procedures in patients with genetic diseases shown to be correctable with BM transplantation after birth. This is especially true of cases in which the disease process affects the patient even before birth (eg, Hurler's syndrome); availability of normal cells/products early in gestation may prevent lasting effects of the disease.
